Total Payments
$5,286
2024 Payments
$444.91
Companies
36
Transactions
199
Medicare Patients
929
Medicare Billing
$78,604
Payment Breakdown by Category
Food & Beverage$4,933 (93.3%)
Education$353.02 (6.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,933 | 192 | 93.3% |
| Education | $353.02 | 7 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $751.33 | 35 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $594.44 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $541.46 | 15 | $0 (2024) |
| Merz North America, Inc. | $400.00 | 3 | $0 (2023) |
| Mylan Pharmaceuticals Inc. | $312.26 | 15 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $288.31 | 14 | $0 (2024) |
| Exeltis, USA Inc. | $250.35 | 13 | $0 (2022) |
| PFIZER INC. | $241.56 | 11 | $0 (2024) |
| Renovia Inc | $190.36 | 4 | $0 (2021) |
| MAYNE PHARMA COMMERCIAL LLC | $185.19 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $444.91 | 18 | Astellas Pharma US Inc ($219.26) |
| 2023 | $1,012 | 26 | Merz North America, Inc. ($400.00) |
| 2022 | $1,129 | 44 | ABBVIE INC. ($279.84) |
| 2021 | $965.72 | 43 | AbbVie Inc. ($281.61) |
| 2020 | $408.40 | 23 | AbbVie Inc. ($129.54) |
| 2019 | $505.68 | 14 | Teva Pharmaceuticals USA, Inc. ($277.20) |
| 2018 | $357.14 | 14 | Teva Pharmaceuticals USA, Inc. ($121.22) |
| 2017 | $462.46 | 17 | Teva Pharmaceuticals USA, Inc. ($196.02) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: WOMENS HEALTH | ||||||
| 11/04/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Biological | ||||||
| 10/14/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Biological | ||||||
| 06/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Womens Health | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Biological | ||||||
| 05/20/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Endocrinology | ||||||
| 04/23/2024 | PFIZER INC. | ESTRING (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: WOMENS HEALTH | ||||||
| 04/09/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $90.95 | General |
| 03/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Biological | ||||||
| 03/13/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: HORMONE THERAPY | ||||||
| 02/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Biological | ||||||
| 02/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 02/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Biological | ||||||
| 02/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Womens Health | ||||||
| 01/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Biological | ||||||
| 01/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/20/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $82.53 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: HORMONE THERAPY | ||||||
| 11/09/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/02/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Biological | ||||||
| 10/03/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Biological | ||||||
| 09/05/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: HORMONE THERAPY | ||||||
| 08/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: Womens Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 336 | 403 | $85,988 | $28,545 |
| 2022 | 5 | 208 | 247 | $53,413 | $17,583 |
| 2021 | 6 | 230 | 258 | $55,214 | $19,721 |
| 2020 | 5 | 155 | 187 | $41,060 | $12,755 |
Total Patients
929
Total Services
1,095
Medicare Billing
$78,604
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 155 | $31,930 | $11,364 | 35.6% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 46 | 50 | $18,750 | $4,742 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 34 | $10,336 | $3,508 | 33.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 69 | 69 | $8,970 | $3,456 | 38.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 66 | 66 | $7,128 | $2,959 | 41.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $8,874 | $2,517 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 99 | $20,394 | $7,431 | 36.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 33 | 39 | $14,625 | $3,355 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $8,874 | $2,896 | 32.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 40 | 40 | $5,200 | $2,052 | 39.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 40 | 40 | $4,320 | $1,850 | 42.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 82 | $16,892 | $6,688 | 39.6% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 34 | 38 | $14,250 | $4,434 | 31.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 49 | 49 | $6,370 | $2,585 | 40.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 27 | 27 | $8,262 | $2,337 | 28.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 48 | 48 | $5,184 | $2,258 | 43.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 14 | $4,256 | $1,419 | 33.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 61 | $12,535 | $3,661 | 29.2% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 31 | 36 | $13,375 | $3,561 | 26.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 24 | $7,296 | $2,307 | 31.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 33 | 33 | $4,290 | $1,677 | 39.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 33 | 33 | $3,564 | $1,549 | 43.5% |
About Dr. Anna Le, MD
Dr. Anna Le, MD is a Medical Specialty healthcare provider based in Annandale, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841382553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Le, MD has received a total of $5,286 in payments from pharmaceutical and medical device companies, with $444.91 received in 2024. These payments were reported across 199 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,933).
As a Medicare-enrolled provider, Le has provided services to 929 Medicare beneficiaries, totaling 1,095 services with total Medicare billing of $78,604. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Specialty
- Other Specialties Obstetrics & Gynecology
- Location Annandale, VA
- Active Since 09/29/2006
- Last Updated 10/25/2019
- Taxonomy Code 261QM2500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841382553
Products in Payments
- AUSTEDO (Drug) $455.84
- Xeomin (Biological) $400.00
- Xulane (Drug) $312.26
- ORIAHNN (Drug) $271.06
- SLYND (Drug) $250.35
- ORILISSA (Drug) $241.01
- Veozah (Drug) $234.51
- MYFEMBREE (Drug) $194.73
- Leva Pelvic Floor Trainer (Device) $190.36
- PREMARIN (Drug) $185.41
- Mirena (Drug) $166.94
- OVA1 (Device) $144.00
- AJOVY (Drug) $138.60
- INJECTAFER (Drug) $130.91
- Kyleena (Drug) $121.37
- LO LOESTRIN FE (Drug) $106.81
- LILETTA (Drug) $100.44
- RS Harmony Test Related Products (Device) $98.38
- SOLOSEC (Drug) $84.81
- MYRISK (Device) $82.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.